Interferon-β1b Treatment in Neuromyelitis Optica

Publisher： Karger

E-ISSN： 1421-9913|62|3|167-170

ISSN： 0014-3022

Source： European Neurology, Vol.62, Iss.3, 2009-07, pp. : 167-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β1b in Multiple Sclerosis: Effect on Progression of Disability and Clinical Markers of Treatment Response

By  

European Neurology, Vol. 60, Iss. 6, 2008-09 ,pp. : 279-284

Karger

Access to resources Recommend Favorite

Apolipoprotein Alleles and the Response to Interferon-β-1b in Multiple Sclerosis

By  

European Neurology, Vol. 65, Iss. 3, 2011-02 ,pp. : 132-137

Karger

Access to resources Recommend Favorite

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

Aquaporin-1 Antibody in Neuromyelitis Optica Patients

By  

European Neurology, Vol. 72, Iss. 5-6, 2014-09 ,pp. : 271-272

Karger

Access to resources Recommend Favorite

Interferon‐β Modulates Inflammatory Response in Cerebral Ischemia

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 1, 2016-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite